A modular set of blocks from MIT can be snapped together to build an array of medical diagnostics, enabling smaller labs to customize their own tests.

The partners will build Longenesis’ blockchain-enabled longitudinal health data platform into Nebula’s emerging genomics-focused offering.

AstraZeneca is partnering with Emulate to incorporate organ-on-a-chip technology into the pharma giant’s R&D program.

Officials put the process on the chopping block after determining it is confusing, inefficient and unlikely to lead to the decision being overturned.

Digital Surgery aims to bring step-by-step roadmaps to the operating room, through a partnership with two U.K. hospitals to chart out their procedures.

Illumina has bought Edico Genome and its Dragen next-generation sequencing and data analysis platform. The terms of the deal were not disclosed.

The cell-sampling device is an encapsulated balloon that can quickly gather samples from the distal esophagus when swallowed.

Implandata Ophthalmic announced a first closing of a series C round of funding.

The co-development agreement with BioSerenity builds on 18 months of research into connected fabrics and how the device will fit into care pathways.

The $4.4 million award sets Talis up to work on a molecular diagnostic capable of detecting the bacteria in patient samples within 20 minutes.